Pharmacy & Biological SciencesCategory
A spike in cases of children with a rare neurological disease that causes polio-like symptoms has health officials scrambling to understand the illness.
Of the roughly $23.3 billion in sales growth seen by 45 top pharmaceutical products, $14.3 billion of that has been tied to price increases, not demand.
Drug companies typically have less than 10 years of exclusive rights once a drug hits the marketplace. They can extend their monopolies by layering in secondary patents.
A third of the new awards aim to accelerate cancer research, and another 25% of the new awards fund studies evaluating drug products for rare endocrine disorders.
The price of insulin in the U.S. has more than doubled since 2012. Because of this, some diabetics have been forced to take drastic measures, like rationing their insulin.
The guidances issued today by the FDA are part of a larger initiative by the administration to increase patient access to high-quality generics.
Americans have zero immunity against the deadly H7N9 flu, and China is refusing to share much-needed samples with U.S. Researchers hoping to combat a potential outbreak.
On the heels of a massive EpiPen shortage, the U.S. Food and Drug Administration has approved the first generic alternative.
Three months after President Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
Digital ads for prescriptions are approaching parity with TV ads, with an even larger percentage of patients who saw ads online asking their doctors about specific medications.